You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Characteristics of all included HIV-1 patients and patients included in the years 2002 to 2005 and 2006 to 2007

From: Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Characteristics Categories Total 2002-2005 2006-2007
Patients   4317 2687 1630
Continent of origin, no (%) Western Europe 2404 (56) 1608 (60) 796 (49)
Eastern Europe & Central Asia 919 (21) 424 (16) 495 (30)
Sub-Saharan Africa 472 (11) 323 (12) 149 (9)
Other 354 (8) 190 (7) 164 (10)
Unknown 168 (4) 142 (5) 26 (2)
Gender, no. (%) Male 3411 (79) 2080 (77) 1331 (82)
Risk group, no. (%) MSM 2084 (48) 1230 (46) 854 (52)
Hetero 1501 (35) 1004 (37) 497 (30)
Injecting drug use 355 (8) 208 (8) 147 (9)
Unknown 377 (9) 245 (9) 132 (8)
Subtype, no. (%) B 2855 (66) 1777 (66) 1078 (66)
non-B 1381 (32) 849 (32) 532 (33)
Unknown 81 (2) 61 (2) 20 (1)
Duration of infection, no (%) <1 year 1236 (29) 724 (27) 512 (31)
1-2 years 144 (3) 77 (3) 67 (4)
Unknown 2937 (68) 1886 (70) 1051 (64)
Plasma HIV-RNA, median (IQR), log copies/ml 4.9 (4.3-5.3) 4.9 (4.3-5.3) 4.8 (4.2-5.4)
CD4 cell count, median (IQR), cells/mm3 352 (180–540) 343 (163–533) 370 (210–548)
Age, median years (IQR) 35 (29–42) 35 (29–42) 35 (29–42)